Fundz

This Biotech Startup Just Raised $105M to Extinguish Inflammation at the Source

PRIVATEFeb 11, 2024

Amount Raised

$105 Million

Round Type

Funding Round

SkokiePharmaceutical Manufacturing

Description

Cour Pharmaceuticals has raised $105 million to further develop its nanoparticle-based therapies and demonstrate how its approach to inflammation stands apart from other immunology peers.

Quick answer

COUR Pharmaceuticals raised $105 Million in a Funding Round round, dated February 11, 2024. COUR Pharmaceuticals is based in Skokie, Illinois, United States.

How much did COUR Pharmaceuticals raise?
COUR Pharmaceuticals raised $105 Million in a Funding Round round on February 11, 2024.
What does COUR Pharmaceuticals do?
We are a group of dedicated scientific, medical, and business professionals who are driven to find treatments and cures to a variety of diseases.
Where is COUR Pharmaceuticals based and how big is it?
COUR Pharmaceuticals is based in Skokie, Illinois, United States.
Who are the decision-makers at COUR Pharmaceuticals?
Fundz holds 2 contacts at COUR Pharmaceuticals, including the Vice President of Quality. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical Manufacturing around the same time

Companies in the same sectors as COUR Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Zeno Health raised $25M (Series C) on February 27, 2024.
  • XORTX Therapeutics raised $2.5M (Seed) on February 19, 2024.
  • DUDE CHEM raised $6.5M (Funding Round) on February 7, 2024.
  • Orexa raised $940K (Seed) on February 2, 2024.
  • 3Daughters raised $2M (Seed) on January 22, 2024.
  • Comanche Biopharma raised $75M (Series B) on January 18, 2024.

Who to call at COUR Pharmaceuticals, and when

A new round usually means COUR Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day COUR Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at COUR Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at COUR Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

COUR Pharmaceuticals

Location

Skokie, Illinois, United States

About

We are a group of dedicated scientific, medical, and business professionals who are driven to find treatments and cures to a variety of diseases. By attacking the disease directly with our novel nanoparticle-based technologies and working strategically with our medical and scientific partners we seek to provide treatments and cures previously unavailable to doctors and their patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment COUR Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsStan R., Vice President of Quality hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for COUR Pharmaceuticals's next move

See what Strategic adds

COUR Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.